# GreenMark Biomedical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/greenmark-biomedical

- Industry: Materials
- Headquarters: East Lansing, US
- Website: www.greenmark.bio
- Total disclosed funding: $1.3M
- Latest round: Seed (Mar 20, 2019)
- Investors on record: 6

## About

GreenMark Biomedical Inc. develops innovative dental health products that enhance oral care through non-invasive solutions, focusing on dental sensitivity and early caries detection.GreenMark Biomedical Inc. is a dental health product company founded in 2016 and headquartered in East Lansing, US. The company specializes in innovative oral care solutions and is led by CEO Steven Bloembergen, who has a notable history in the industry. GreenMark has completed three funding rounds, with the most recent being a VENTURE DEBT round in January 2022, raising USD 0.83 mn from investors including Blue Water Angels and the University of Michigan (Ross School of Business). To date, the company has raised a total of USD 0.67 mn.GreenMark Biomedical Inc. specializes in innovative dental health products aimed at enhancing oral care through non-invasive solutions. Their flagship product, CrystLCare™ Biorestorative, is a fluoride-free dental strip designed to provide immediate and long-lasting relief from dental hypersensitivity by depositing calcium and phosphate minerals that form hydroxyapatite crystals to occlude exposed dentinal tubules and fill enamel porosities. Additionally, the LumiCare™ Caries Detection Rinse utilizes fluorescent particles to aid in the early detection of carious lesions during routine dental exams, illuminating early-stage cavities that are typically undetectable. These products cater to a diverse clientele, including dental practitioners, hygienists, and patients, and are distributed in markets across North America.GreenMark Biomedical Inc. generates revenue through direct-to-consumer sales and partnerships with dental professionals who utilize their products in clinical settings. Transactions typically occur as one-time purchases of their dental strips and rinses, with the potential for repeat customers seeking ongoing relief from dental sensitivity. The CrystLCare™ Biorestorative strips and LumiCare™ Caries Detection Rinse are sold directly to patients and dental offices, positioning the company to benefit from both retail and B2B sales strategies.In January 2022, GreenMark Biomedical Inc. raised USD 830,000 in VENTURE DEBT funding to support its growth initiatives. The company plans to expand its product line with upcoming innovations aimed at enhancing dental health, although specific release dates for new products have not been disclosed. Additionally, GreenMark intends to enter new geographic markets across North America, focusing on regions with emerging dental practices. The recent funding will be utilized to facilitate these expansions and further develop their product offerings.

## Funding rounds

- Seed, Mar 20, 2019, $0.7M — University of Michigan (Ross School of Business), Red Cedar Ventures, Invest Michigan
- Seed, Jun 29, 2018, $0.6M — Invest Detroit, Blue Water Angels, Biosciences Research & Commercialization Center

## Investors

- Invest Detroit (https://capitalatlas.ai/funds/invest-detroit) — Seed
- Blue Water Angels — Seed
- Biosciences Research & Commercialization Center (https://capitalatlas.ai/funds/biosciences-research-commercialization-center) — Seed
- University of Michigan (Ross School of Business) (https://capitalatlas.ai/funds/university-of-michigan-ross-school-of-business) — Seed
- Red Cedar Ventures (https://capitalatlas.ai/funds/red-cedar-ventures) — Seed
- Invest Michigan (https://capitalatlas.ai/funds/invest-michigan) — Seed